Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533110) titled 'Evaluation Of The Success Rate of NOVAMag(R) SHIELD In Two Different Advanced Bone Defects: A Randomized Controlled Trial' on April 9.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Egas Moniz - Cooperativa de Ensino Superior, CRL
Condition:
Alveolar Buccal Bone Dehiscences
Socket Type 3 Subclass B
Socket Type 3 Subclass C
Intervention:
Procedure: SHIELD technique with NOVAMag membrane
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: March 19, 2026 ...